# The Vascular Group

> The Vascular Group is a VC fund in Albany backing Biotechnology, Medical and Biopharma. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Albany, United States
- Total investments: 2
- Last investment: Jan 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/the-vascular-group-pllc
- Website: http://albanyvascular.com
- Facebook: https://www.facebook.com/the-vascular-group-pllc-170969169634245

The Vascular Group is a medical practice company that delivers art diagnostic and therapeutic procedures.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Novamigra Therapeutics | Novamigra Therapeutics is an innovative pharmaceutical company and a spin-out of VRG Therapeutics, dedicated to developing patient-centric therapies for migraine prevention. By leveraging novel mechanisms of action and rigorous translational science, the company aims to address the significant unmet needs in migraine prophylaxis and improvelong-term outcomes for patients worldwide. | $3.5M | Venture - Series Unknown | Jan 09, 2026 |  |
| VRG Therapeutics | VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies. | $5.5M | Series A | Aug 14, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [PMK Ventures](https://shizune.co/investors/profile/pmk-ventures) — VC Fund, 1 deal together
- [Széchenyi Capital Fund Management](https://shizune.co/investors/profile/sz-chenyi-capital-fund-management) — VC Fund, 1 deal together
- [SZTA](https://shizune.co/investors/profile/szta) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Hiventures](https://shizune.co/investors/profile/hiventures) — VC Fund
- [Portfolion](https://shizune.co/investors/profile/portfolion) — VC Fund
- [Bonitás Ventures](https://shizune.co/investors/profile/bonit%C3%A1s-venture-capital-fund) — VC Fund

## Featured in investor lists
- [All Investors in Hungary](https://shizune.co/investors/investors-hungary)
- [All VC Funds in Hungary](https://shizune.co/investors/vc-funds-hungary)
- [Biotechnology Investors in Hungary](https://shizune.co/investors/biotechnology-investors-hungary)
- [Biotechnology VC Funds in Hungary](https://shizune.co/investors/biotechnology-vc-funds-hungary)
- [Health Care Investors in Hungary](https://shizune.co/investors/health-care-investors-hungary)
- [Biotech VC Funds in Hungary](https://shizune.co/investors/biotech-vc-funds-hungary)

## FAQ

### What does The Vascular Group invest in?

The Vascular Group invests primarily in Biotechnology, Medical and Biopharma startups, most often at Series A and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Hungary. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did The Vascular Group last invest?

The most recent investment recorded for The Vascular Group closed in Jan 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co